
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases.
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.325 | -8.96551724138 | 3.625 | 3.82 | 3.295 | 485920 | 3.57118771 | CS |
4 | -0.26 | -7.30337078652 | 3.56 | 3.96 | 3.2109 | 754516 | 3.58891845 | CS |
12 | -2.43 | -42.4083769634 | 5.73 | 5.79 | 3.02 | 804344 | 3.84875027 | CS |
26 | 1.03 | 45.3744493392 | 2.27 | 7.27 | 2.045 | 1115940 | 4.12637289 | CS |
52 | -11.66 | -77.9411764706 | 14.96 | 19.9488 | 1.575 | 1862489 | 3.80682178 | CS |
156 | -23.19 | -87.5424688562 | 26.49 | 41.9297 | 1.575 | 1359952 | 14.26907672 | CS |
260 | -17.7 | -84.2857142857 | 21 | 41.9297 | 1.575 | 1321468 | 14.3319912 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales